{"title":"What Procedural Ethics Can Learn from the Quest for Moral Justification for the \"Rule of Rescue\".","authors":"Bernard Keating","doi":"10.12927/hcpap.2023.26997","DOIUrl":null,"url":null,"abstract":"<p><p>In this issue, Sirrs and colleagues (2023) provide a very informative picture of the value and cost of policies to promote orphan drug development. They examine the influence of these policies on pharmaceutical research and development, the proliferation of rare diseases, the prohibitive costs and the loopholes of these policies. One section of the paper identifies the ethical issues and proposes a response to the challenge of integrating the utility perspectives of pharmacoeconomic analyses with those of treatment access claims formulated from a deontological perspective. Their proposal is essentially that of procedural ethics. I enter the ethical debate obliquely by looking at the rule of rescue phenomenon observed by Albert R. Jonsen (Jonsen 1986). I explore the twists and turns of the discussion on this subject and assume the perspective of authors who give significant weight to the symbolic value of respecting it. In conclusion, I take up the symbolic question by arguing that the challenge of preserving the aura of legitimacy that must surround political decisions sometimes requires distancing oneself from sound recommendations, which, even if they are the result of an ideal procedure, will nevertheless be perceived as unjust and insensitive.</p>","PeriodicalId":35522,"journal":{"name":"Healthcare Papers","volume":"21 1","pages":"38-43"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare Papers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12927/hcpap.2023.26997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
In this issue, Sirrs and colleagues (2023) provide a very informative picture of the value and cost of policies to promote orphan drug development. They examine the influence of these policies on pharmaceutical research and development, the proliferation of rare diseases, the prohibitive costs and the loopholes of these policies. One section of the paper identifies the ethical issues and proposes a response to the challenge of integrating the utility perspectives of pharmacoeconomic analyses with those of treatment access claims formulated from a deontological perspective. Their proposal is essentially that of procedural ethics. I enter the ethical debate obliquely by looking at the rule of rescue phenomenon observed by Albert R. Jonsen (Jonsen 1986). I explore the twists and turns of the discussion on this subject and assume the perspective of authors who give significant weight to the symbolic value of respecting it. In conclusion, I take up the symbolic question by arguing that the challenge of preserving the aura of legitimacy that must surround political decisions sometimes requires distancing oneself from sound recommendations, which, even if they are the result of an ideal procedure, will nevertheless be perceived as unjust and insensitive.
在这一期中,Sirrs及其同事(2023)提供了一幅非常有信息量的图片,说明了促进孤儿药开发的政策的价值和成本。他们审查了这些政策对药物研究和开发的影响、罕见疾病的扩散、高昂的成本以及这些政策的漏洞。论文的一个部分确定了伦理问题,并提出了对整合药物经济学分析的效用观点与从义务论角度制定的治疗机会主张的挑战的回应。他们的建议本质上是程序伦理的建议。我通过观察Albert R. Jonsen (Jonsen 1986)观察到的拯救规则现象,间接地进入了伦理辩论。我探索了关于这个主题的讨论的曲折,并假设作者的观点,他们给予尊重它的象征价值的重要权重。最后,我在讨论象征性问题时指出,维护必须围绕政治决定的合法性光环的挑战有时需要与合理的建议保持距离,这些建议即使是理想程序的结果,也会被认为是不公正和不敏感的。
期刊介绍:
Integrating community-based health and social care has grabbed international attention as a way of addressing the needs of aging populations while contributing to health systems" sustainability. However, integrating initiatives in different jurisdictions work (or do not work) within very various.